Clinical research progress of novel antituberculosis drugs on multidrug-resistant tuberculosis

被引：0
|
作者：
Zhong, Xinxin [1 ]
Lin, Ao [2 ]
Luo, Jian [1 ]
Li, Yeqin [1 ]
Chen, Jinlan [1 ]
Ning, Chao [1 ]
Cao, Fu [1 ,3 ]
机构：
[1] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, Yulin 537000, Guangxi, Peoples R China
[2] Red Cross Hosp Yulin City, Dept Cardiothorac Surg, Yulin 537000, Guangxi, Peoples R China
[3] Red Cross Hosp Yulin City, Dept Pulm & Crit Care Med, 1 Jinwang Rd, Yulin 537000, Guangxi, Peoples R China
来源：
POSTGRADUATE MEDICAL JOURNAL | 2024年 / 100卷 / 1184期
关键词：
antituberculosis drugs; multidrug-resistance; mycobacterium; chemotherapy; MYCOBACTERIUM-TUBERCULOSIS; BACTERICIDAL ACTIVITY; IN-VITRO; MDR-TB; BEDAQUILINE; REGIMENS; PRETOMANID; DISCOVERY; DELAMANID; EFFICACY;
D O I：
10.1093/postmj/qgad140
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Multidrug-resistant tuberculosis (MDR-TB) has become a critical challenge to public health, and the prevention and treatment of MDR-TB are of great significance in reducing the global burden of tuberculosis. How to improve the effectiveness and safety of chemotherapy for MDR-TB is a pressing issue that needs to be addressed in tuberculosis control efforts. This article provides a comprehensive review of the clinical application of new antituberculosis drugs in MDR-TB, aiming to provide a scientific basis for the prevention and treatment strategy of MDR-TB.
引用
收藏
页码：366 / 372
页数：7
相关论文
共 50 条
  • [31] Failure of chemoprophylaxis with standard antituberculosis agents in child contacts of multidrug-resistant tuberculosis cases
    Sneag, Darryl B.
    Schaaf, H. Simon
    Cotton, Mark F.
    Zar, Heather J.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2007, 26 (12) : 1142 - 1146
  • [32] Resistance to second-line drugs in multidrug-resistant tuberculosis
    Nyang'wa, Bern-Thomas
    Brigden, Grania
    du Cros, Philipp
    Shanks, Leslie
    LANCET, 2013, 381 (9867): : 625 - 625
  • [33] New drugs to treat multidrug-resistant tuberculosis: the case for bedaquiline
    Leibert, Eric
    Danckers, Mauricio
    Rom, William N.
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 597 - 602
  • [34] Bedaquiline: A Novel Diarylquinoline for Multidrug-Resistant Pulmonary Tuberculosis
    Deshkar, Anuradha T.
    Shirure, Prashant A.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (08)
  • [35] Bedaquiline: A novel antitubercular drug for multidrug-resistant tuberculosis
    Nagabushan, H.
    Roopadevi, H. S.
    JOURNAL OF POSTGRADUATE MEDICINE, 2014, 60 (03) : 300 - 302
  • [36] Clinical implications of the global multidrug-resistant tuberculosis epidemic
    Kumar, Kartik
    Abubakar, Ibrahim
    CLINICAL MEDICINE, 2016, 16 (06) : 565 - 570
  • [37] MULTIDRUG-RESISTANT TUBERCULOSIS - REPLY
    EDLIN, BR
    TOKARS, JI
    CASTRO, KG
    DOOLEY, SW
    NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (16): : 1174 - 1174
  • [38] Treatment of multidrug-resistant tuberculosis
    Colebunders, R
    Apers, L
    Shamputa, IC
    LANCET, 2004, 363 (9416): : 1240 - 1240
  • [39] Transmission of multidrug-resistant tuberculosis
    Schaaf, HS
    Van Rie, A
    Gie, RP
    Beyers, N
    Victor, TC
    Van Helden, PD
    Donald, PR
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (08) : 695 - 699
  • [40] Multidrug-resistant Tuberculosis in Children
    Shah, Ira
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2012, 31 (09) : 970 - 972
12345